High mortality associated with precluded coronary artery bypass surgery caused by severe distal coronary artery disease

Circulation

Volumn 112, Issue 9 SUPPL., 2005, Pages

  Da Rocha, Antônio Sérgio Cordeiro ^a,b   Dassa, Nella Paula Rodrigues ^a   Pittella, Felipe José Monassa ^a   Barbosa, Odilon Nogueira ^a   Brito, José Oscar Reis ^a   Tura, Bernardo ^a   Da Silva, Paulo Roberto Dutra ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGIA   (Brazil)

^b NONE   (Brazil)

Author keywords

Atherosclerosis; Coronary disease; Grafting; Mortality; Prognosis; Revascularization; Surgery; Survival

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REVASCULARIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; STABLE ANGINA PECTORIS; STATISTICAL ANALYSIS; SURGICAL MORTALITY; UNSTABLE ANGINA PECTORIS;

AGED; BRAZIL; CARDIOVASCULAR AGENTS; CAUSE OF DEATH; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; CORONARY ARTERY BYPASS; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 24644431561     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.104.525717     Document Type: Article

References (25)

1. Okrainec K, Banerjee DK, Eisenberg MJ. Coronary artery disease in the developing world. Am Heart J. 2004;148:7-15.
2. www.who.int/mediacenter/news/releases/2004/pr68/em/print.html
3. www.datasus.gov.br
4. Ferguson TB, Hammill BG, Peterson ED, DeLong ER, Grover FL, for the STS National Database Committee. A decade of change-risk profiles and outcomes for isolated coronary-artery bypass grafting procedures, 1990-1998: a report from the STS National Database Committee and the Duke Clinical Research Institute. Ann Thorac Surg. 2002;73:480-490.
5. Ferreira AC, Peter AA, Salerno TA, Bolooki H, Marchena E. Clinical impact of drug-eluting stents in changing referral practices for coronary surgical revascularization in a tertiary care center. Ann Thorac Surg. 2003;75:485-489.
6. Holmes DR, Firth BG, Wood DL. Paradigm shifts in cardiovascular medicine. J Am Coll Cardiol. 2004;43:507-512.
7. Rihal CS, Raco DL, Gersh BJ, Yusuf S. Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina. Review of the evidence and methodological considerations. Circulation. 2003;108:2439-2445.
8. Caracciolo EA, Davis KB, Sopko G, Kaiser GC, Corley SD, Schaff H, Taylor HÁ, Chaitman DR, for the CASS Investigators. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325-2334.
9. Bounous EP, Mark DB, Pollock BG, Hlatky MA, Harrel FE Jr, Lee KL, Rankin S, Wechsler AS, Pryor DB, Califf RM. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation. 1988;78(suppl I):I151-I157.
10. ACC/AHA 2004 guidelines update for coronary artery bypass graft surgery. A report of the Am College of Cardiology and Am Heart Association Task Force on Practice Guidelines. www.acc.org.
11. Graham MH, Chambers RJ, Davies RF. Angiographic quantification of diffuse coronary artery disease. Reliability and prognostic value for bypass operations. J Thorac Cardiovasc Surg. 1999;118:618-627.
12. Mukherjee M, Bhat DL, Roc MT, Patel V, Ellis SG. Direct myocardial revascularization and angiogenesis-how many patients might be eligible? Am J Cardiol. 1999;84:598-600.
13. Mannheimer C, Camici P, Chester MR, Collins A, DeJongste M, Eliassont T, Follath F, Hallemans I, Herlitz J, Lüscher T, Pasic M, Thelle D. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the treatment of the treatment of refractory angina. Eur Heart J. 2003;23:355-370.
14. Kandzari DE, Lam LC, Eisenstein EL, Clapp-Channing N, Fine JT, Califf RM, Mark DB, Jollis JG. Advanced coronary artery disease: appropriate end points for trials of novel therapies. Am Heart J. 2001;142:843-851.
15. Landolfo CK, Sandolfo KP, Hughes C, Coleman ER, Coleman RB, Lowe JE. Intermediate-term clinical outcome following transmyocardial laser revascularization in patients with refractory angina pectoris. Circulation. 1999;100(suppl II):II-128-II-133.
16. Allen KB, Dowling RD, Fudge TL, Schoettle GP, Selinger SL, Gangahar DM, Angell WW, Petracek MR, Shaar CJ, O'Neill WW. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med. 1999;341:1029-1036.
17. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS trial study group. N Engl J Med. 1987;316:1429-1435.
18. Effects of enalapril on survival of patients with reduced left ventricular ejection fraction and congestive heart failure. The SOLVD investigators. N Engl J Med. 1991;325:293-302.
19. Bristow MR, Saxon LA, Boehmer J, Jrueger S, Kass DA, De Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM, for the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Investigators. N Engl J Med. 2004;350:2140-2150.
20. Young JB, Dunlap ME, Pfeffer MA, Probsfield JL, Cohen-Solal A, Dietz R, Granger CB, Htadec J, Kuch JM, McKelvie RS, McMurray JJV, Michelson EL, Olofsson B, Ostergren J, Held P, Solomon SD, Yusul S, Swedbweg K, for the Candesartan in Heart Failure Assessment of Reduction in Mortality and morbidity (CHARM) investigators and committees. Circulation. 2004;110:2618-2626.
21. Pajunen P, Nieminen MJ, Taskinen MR, Syvänne M. Quantitative comparison of angiographie characteristics of coronary artery disease in patients with noninsulin-dependent diabetes mellitus compared with matched nondiabetic control subjects. Am J Cardiol. 1997;80:550-556.
22. Morgan KP, Kapur A, Beatl KJ. Anatomy of coronary disease in diabetics patients: an explanation for the poorer outcome after percutaneous coronary intervention and potencial target for intervention. Heart. 2004;90:732-738.
23. Goraya TY, Leibson CL, Palumbo PJ, Weston AS, Killian JM, Pfeifer EA, Jacobsen SJ, Frye RL, Roger VL. Coronary atherosclerosis in diabetes mellitus. A population-based autopsy study. J Am Coll Cardiol. 2002;40:946-953.
24. Hammond T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. J Am Coll Cardiol. 2000;36:355-365.
25. Sobel B, Frye R, Detre KM. Burgeoning dilemmas in the management of diabetes and cardiovascular disease. Rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. Circulation. 2003;107:636-642.